FDA picks critic of COVID boosters to be new top vaccines official

The Food and Drug Administration announced Tuesday it has picked a new head of its center charged with vaccine approvals and other biologics products: Dr. Vinay Prasad, a vocal critic of the agency's ... Read More

Moderna's flu/COVID combination vax hit by deprioritization, FDA delay as R&D spend sinks 19%

Moderna is deprioritizing its flu/COVID combination ... combination product is the majority, for convenience, and ultimately on healthcare systems is much less of a burden. You can do twice ... Read More

FDA chief says they're looking at whether to approve COVID shots for next winter

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines ... and product, we can't give an honest evidence ... Read More

COVID vaccine boosters called into question by FDA chief: ‘Void of data’

The FDA chief has called into question whether the agency will approve and authorize the COVID-19 vaccine for ... on the new formulation and product, we can’t give an honest, evidence-based ... Read More

FDA scrutiny of Novavax COVID-19 vaccine sparks uncertainty about other shots

If that’s the new policy, “you ... The FDA had been treating the annual COVID-19 strain updates exactly as it’s done for decades with flu vaccines — not as new products, but existing ... Read More

U.S. health officials inject new uncertainty into approval process for Covid boosters

You can reach Helen on Signal at hbranswell.01. Confusion over the Food and Drug Administration’s delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend when ... Read More

FDA Scrutiny of Novavax COVID Shot Sparks Uncertainty About Other Vaccines

If that's the new policy, "you'd always ... The FDA had been treating the annual COVID-19 strain updates exactly as it's done for decades with flu vaccines -- not as new products, but existing ... Read More